
Vita Life Sciences Ltd
ASX:VLS

Intrinsic Value
The intrinsic value of one
VLS
stock under the Base Case scenario is
2.402
AUD.
Compared to the current market price of 1.815 AUD,
Vita Life Sciences Ltd
is
Undervalued by 24%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Vita Life Sciences Ltd
Fundamental Analysis
Want a deep‑dive on Vita Life Sciences Ltd?
Request it below and we’ll move it up the queue.

Revenue & Expenses Breakdown
Vita Life Sciences Ltd
Balance Sheet Decomposition
Vita Life Sciences Ltd
Current Assets | 58.9m |
Cash & Short-Term Investments | 28.6m |
Receivables | 12m |
Other Current Assets | 18.3m |
Non-Current Assets | 13m |
PP&E | 10.3m |
Intangibles | 50k |
Other Non-Current Assets | 2.6m |
Free Cash Flow Analysis
Vita Life Sciences Ltd
AUD | |
Free Cash Flow | AUD |
Earnings Waterfall
Vita Life Sciences Ltd
Revenue
|
79.5m
AUD
|
Cost of Revenue
|
-32.3m
AUD
|
Gross Profit
|
47.2m
AUD
|
Operating Expenses
|
-35.4m
AUD
|
Operating Income
|
11.9m
AUD
|
Other Expenses
|
-3.1m
AUD
|
Net Income
|
8.8m
AUD
|
VLS Profitability Score
Profitability Due Diligence
Vita Life Sciences Ltd's profitability score is 63/100. The higher the profitability score, the more profitable the company is.

Score
Vita Life Sciences Ltd's profitability score is 63/100. The higher the profitability score, the more profitable the company is.
VLS Solvency Score
Solvency Due Diligence
Vita Life Sciences Ltd's solvency score is 73/100. The higher the solvency score, the more solvent the company is.

Score
Vita Life Sciences Ltd's solvency score is 73/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
VLS Price Targets Summary
Vita Life Sciences Ltd
Dividends
Current shareholder yield for VLS is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
VLS
stock under the Base Case scenario is
2.402
AUD.
Compared to the current market price of 1.815 AUD,
Vita Life Sciences Ltd
is
Undervalued by 24%.